{"id":25230,"date":"2016-04-13T03:53:36","date_gmt":"2016-04-13T01:53:36","guid":{"rendered":"http:\/\/www.invarena.cz\/?p=25230"},"modified":"2016-04-13T03:53:36","modified_gmt":"2016-04-13T01:53:36","slug":"mobilni-aplikace-pro-pacienty-s-roztrousenou-sklerozou","status":"publish","type":"post","link":"https:\/\/www.invarena.cz\/?p=25230","title":{"rendered":"Mobiln\u00ed aplikace pro pacienty s roztrou\u0161enou skler\u00f3zou"},"content":{"rendered":"

Mobiln\u00ed aplikace pro pacienty s\u00a0roztrou\u0161enou skler\u00f3zou RS Kompas+, kterou pro farmaceutickou spole\u010dnost vyrobila \u010desk\u00e1 spole\u010dnost Pears Health Cyber, byla mezi TOP finalisty leto\u0161n\u00ed jarn\u00ed mezin\u00e1rodn\u00ed p\u0159ehl\u00eddky inovativn\u00edch projekt\u016f farmaceutick\u00fdch firem Eyeforpharma Barcelona Awards. <\/strong><\/p>\n

Do sout\u011b\u017ee bylo p\u0159ihl\u00e1\u0161eno v\u00edce ne\u017e 200 projekt\u016f v\u00a0p\u011bti kategori\u00edch a i kdy\u017e cenu leto\u0161n\u00edho 14. ro\u010dn\u00edku z\u00edskala spole\u010dnost Sanofi za program boje proti mal\u00e1rii, aplikace pro pacienty s\u00a0RS byla v\u00a0prvn\u00ed p\u011btici nej\u00fasp\u011b\u0161n\u011bj\u0161\u00edch projekt\u016f mezi 80 dal\u0161\u00edmi projekty v\u00a0kategorii Most Valuable Patient Initiative or Service. <\/p>\n

\u201eRS Kompas+\u00a0je mobiln\u00ed aplikace, kter\u00e1 pacient\u016fm s\u00a0roztrou\u0161enou skler\u00f3zou p\u0159ipom\u00edn\u00e1 u\u017eit\u00ed l\u00e9ku a porad\u00ed m\u00edsto jeho vpichu. Nen\u00ed to bud\u00edk, um\u00ed mnohem v\u00edc. Pr\u00e1vem je proto pova\u017eov\u00e1na za osobn\u00edho asistenta nemocn\u00e9ho, chytr\u00e9ho a diskr\u00e9tn\u00edho,\u201c shrnuje Jitka Hrab\u00e1nkov\u00e1, kter\u00e1 v\u00a0Barcelon\u011b aplikaci za spole\u010dnost Pears Health Cyber prezentovala HealthhhE. <\/p>\n

Mobiln\u00ed telefon m\u016f\u017ee tedy u\u010dit pacienta s\u00a0RS aplikovat injekce s l\u00e9\u010debnou l\u00e1tkou a p\u0159ipomene, kdy je \u010das na aplikaci l\u00e9ku. Krom\u011b toho nab\u00eddne nejvhodn\u011bj\u0161\u00ed m\u00edsta na t\u011ble, kam l\u00e9\u010debnou l\u00e1tku aplikovat, a umo\u017en\u00ed pacientovi v\u00e9st aplika\u010dn\u00ed den\u00edk.\u00a0Tuto aplikaci vyrobila \u010desk\u00e1 spole\u010dnost Pears Health Cyber pro farmaceutickou spole\u010dnost TEVA.<\/p>\n

\u201eMobiln\u00ed aplikace pro pacienty vyv\u00edj\u00edme u\u017e 3 roky, RS Kompas+ byl jedn\u00edm z\u00a0prvn\u00edch projekt\u016f. T\u011b\u0161\u00ed n\u00e1s jeho \u00fasp\u011bch i trval\u00e1 hodnota, kter\u00e1 nekles\u00e1 \u2013 je pro pacienty nedoceniteln\u00fdm pomocn\u00edkem v\u00a0okam\u017eic\u00edch, kdy pot\u0159ebuj\u00ed poradit, pomoci,\u201c konstatuje Jitka Hrab\u00e1nkov\u00e1. Dod\u00e1v\u00e1, \u017ee aplikace je pro n\u011b jistotou, \u017ee jejich l\u00e9\u010dba nesel\u017ee, proto\u017ee nezapomenou sv\u016fj l\u00e9k u\u017e\u00edt.<\/p>\n

O roztrou\u0161en\u00e9 skler\u00f3ze (RS)<\/strong><\/p>\n

Obecn\u011b jde o onemocn\u011bn\u00ed, kdy lidsk\u00fd imunitn\u00ed syst\u00e9m napad\u00e1 centr\u00e1ln\u00ed nervovou soustavu. Nemoc si sv\u016fj n\u00e1zev nese podle toho, \u017ee RS m\u016f\u017ee tvo\u0159it v\u00edce lo\u017eisek, proto \u201eroztrou\u0161en\u00e1\u201c. <\/p>\n

RS je ve v\u011bt\u0161in\u011b p\u0159\u00edpad\u016f nemoc\u00ed, kter\u00e1 mnoho pacient\u016f potr\u00e1p\u00ed \u201ejen ob\u010das\u201c, p\u0159i akutn\u00ed atace. V remisi se zpravidla c\u00edt\u00ed \u201ezdr\u00e1vi\u201c, a to je sv\u00e1d\u00ed k nedodr\u017een\u00ed l\u00e9\u010debn\u00e9ho sch\u00e9matu. Ze studie GAP (The Global Adherence Project) vypl\u00fdv\u00e1, \u017ee nej\u010dast\u011bj\u0161\u00ed p\u0159\u00ed\u010dinou neu\u017eit\u00ed l\u00e9ku je opomn\u011bn\u00ed (v 50 procentech p\u0159\u00edpad\u016f neaplikace l\u00e9ku), na druh\u00e9m m\u00edst\u011b jsou p\u0159\u00ed\u010diny souvisej\u00edc\u00ed se samotnou injekc\u00ed (32 procent), \u00fanava (15 procent), nevyhovuj\u00edc\u00ed d\u00e1vkov\u00e1n\u00ed (deset procent). <\/p>\n

P\u0159ipom\u00ednky a pomoc se spr\u00e1vnou aplika\u010dn\u00ed technikou jsou proto ty nejcenn\u011bj\u0161\u00ed dovednosti virtu\u00e1ln\u00edho osobn\u00edho asistenta RS Kompas+.<\/p>\n

Dal\u0161\u00ed online pomocn\u00edci pro zdrav\u00ed<\/strong><\/p>\n

Aktu\u00e1ln\u011b si pacienti na cel\u00e9m sv\u011bt\u011b mohou st\u00e1hnout p\u011bt funk\u010dn\u00edch aplikac\u00ed \u010desk\u00e9 spole\u010dnosti Pears Health Cyber. Pom\u00e1haj\u00ed vyhodnotit riziko melanomu k\u016f\u017ee, srde\u010dn\u00edho infarktu, erektiln\u00ed disfunkce, demence a diabetu. Nejstahovan\u011bj\u0161\u00ed je aplikace na riziko demence a srde\u010dn\u00edho infarktu. Aplikace jsou v \u0161esti jazyc\u00edch (angli\u010dtina, \u010de\u0161tina, n\u011bm\u010dina, \u0161pan\u011bl\u0161tina, portugal\u0161tina a francouz\u0161tina). <\/p>\n

\u2192 Diabetes Test \u2013 kalkul\u00e1tor rizika diabetu
\n\u2192 Heart Test \u2013 kalkul\u00e1tor potenci\u00e1lu srde\u010dn\u00edho infarktu
\n\u2192 Dementia Test \u2013 kalkul\u00e1tor detekuj\u00edc\u00ed demenci vhodn\u00fd k opakovan\u00fdm test\u016fm v\u00fdvoje nemoci
\n\u2192 Melanoma Test \u2013 kalkul\u00e1tor rizika rakoviny k\u016f\u017ee
\n\u2192 ED Test \u2013 kalkul\u00e1tor rizika erektiln\u00ed dysfunkce<\/p>\n","protected":false},"excerpt":{"rendered":"

Mobiln\u00ed aplikace pro pacienty s\u00a0roztrou\u0161enou skler\u00f3zou RS Kompas+, kterou pro farmaceutickou spole\u010dnost vyrobila \u010desk\u00e1 spole\u010dnost Pears Health Cyber, byla mezi TOP finalisty leto\u0161n\u00ed jarn\u00ed mezin\u00e1rodn\u00ed […]<\/a><\/p>\n<\/div>","protected":false},"author":1,"featured_media":21736,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-25230","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-zdravi"],"_links":{"self":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts\/25230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=25230"}],"version-history":[{"count":0,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts\/25230\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/media\/21736"}],"wp:attachment":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=25230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=25230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=25230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}